C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles - Wikidata - wikimedia - TriplyDB

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

http://www.wikidata.org/entity/Q28263849

about

Phospholipid scramblase 1 mediates hepatitis C virus entry into host cells Hepatitis C virus proteins Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation.Expression of dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin on dendritic cells generated from human peripheral blood monocytes.Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.CD209 genetic polymorphism and tuberculosis disease.Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN)Sequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantonese.Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.Association of MRC-1 and IL-28B with the treatment outcome of hepatitis C: a case control study Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells.Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.Viruses and dendritic cells: enemy mine.Hepatitis C virus entry.Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels.Dendrimers as therapeutic agents: a systematic review.Adaptive immunity to the hepatitis C virus.Recent advances in hepatitis C virus cell entry.The tug-of-war between dendritic cells and human chronic viruses.Hepatitis C virus entry: beyond receptors.Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins.Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.

P2860

Q24318390-8BDE70B1-FF67-427F-8C47-AF4D459A11BD Q24563969-346DB816-3D89-4B57-8316-F9D6DABA38EA Q27469468-42399EA3-47EC-4123-A445-E7AF86700DFF Q27469844-AF378EB5-21D6-4C30-A89A-20C6A561BCA7 Q27472768-E12E83C5-83DC-40C9-85BE-A5B29C8C1A18 Q27472821-B52549A1-79C9-4CBD-B63B-A90180DA00CD Q27473226-B0293D69-739B-4B04-82A0-80E1923D6F0B Q27473287-4A231195-6B06-4F9B-837F-15C0D310B0F0 Q27477606-1D4861D7-5E03-44C9-B8AC-14CF01C066B4 Q27477777-B346D640-94A9-4590-BFB6-B0443369DFC7 Q27480927-C61FFF86-395E-432A-9A97-F5BBB5B766CA Q27485638-F1CD2E9F-FC44-4564-A86B-B94E82FC4F08 Q27487399-0F1C8EA2-7C84-49A7-A42D-A7955B08824E Q27487754-6F1AFC53-E0D6-4512-8CB7-BD91D0FD176E Q27487872-F3BDED9F-CD8E-4EC8-93EC-2335FD6AF249 Q27490526-2010B10B-EB0C-4C90-AE84-C6DA0227EFF3 Q30438047-37C783FC-AA4A-4542-A1F6-122EAFA5C939 Q33234354-E34F94A2-EC2B-4864-B2CB-42D86696C0B8 Q33260408-A05418B7-A78E-4A09-9F92-22FB7C4598AC Q33312941-2604D7F6-EAD2-48D1-8429-9BFFC945DC5F Q33516234-BBE14DFE-2CBB-4AC9-AA5D-6F9842AF74A5 Q33582027-A5D36D29-BCD1-4A28-8979-A79109BF2B8C Q33743665-E1D5972D-2A99-4E65-A717-DD54B70F5635 Q33877381-E3C70916-2AF3-48E5-9799-795358966B81 Q33903850-9CB50FFE-1503-4BB6-9273-85BE2CFB0C8A Q34016463-55FC5DFB-94ED-4153-BF82-06773A7812CE Q34576498-052B5D6B-BA30-42C0-A69B-E23FD3A61046 Q35107420-084B6B0B-2CE2-48A3-941B-FDD08D33FF69 Q36577153-295EE73C-2923-436F-B662-8331FD80DA34 Q36729667-D16B17EE-456A-445F-9CCB-3121A4F1CDA3 Q36946317-F4634723-75C7-41B6-A6C1-54FDFF063B53 Q36956517-A449EB94-D3B7-4298-8210-0D7CF043CD96 Q37043558-33AEB936-691D-4275-94F7-0134D98D3C9D Q37585659-AAB5E804-69E3-449E-85CD-7BE0317C585F Q37805839-9E169299-762F-4A9B-8B62-26E34D846BC9 Q37945199-7C13F415-FB94-4C08-BB3D-F6B28C79D1C6 Q37952807-786A2BC9-65C7-4E85-8FDE-725AFCB04AC9 Q37990884-E3ADF005-2934-454A-B968-5D1878B9CB33 Q38034665-15C29BB4-6E41-45CA-A33E-9CBFE829B742 Q38106964-12E0F078-BA92-44C2-8CEE-90A700C3CD5A

P2860

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

http://www.wikidata.org/entity/Q28263849

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@ast

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@en

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@nl

type

label

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@ast

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@en

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@nl

prefLabel

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@ast

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@en

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@nl

P1433

Q28263849-525E6142-3EC3-4739-A1FC-C67DF1971BB3

P1476

Q28263849-E8A11176-5809-4AEA-95DF-42CDE9E117B8

P2093

Q28263849-57BEBA19-0093-4781-A885-CB26A7D3A43D

Q28263849-655B9B4A-FCCE-44C3-A70C-7A8D70AC0EA4

Q28263849-C92B3F0D-26C7-422F-AD93-1D4F28888186

P2860

Q28263849-037B10C3-8180-4DFD-92A0-68841FED9785

Q28263849-08FAC8ED-6469-45E5-ACEC-513C02B3E805

Q28263849-0924A831-7528-4EB9-BB7A-6A5A946B58E6

Q28263849-0ADC05A1-2F60-4017-9B82-5F68E2D7C448

Q28263849-0BA5F970-D4CA-4A93-99D8-138F6EE06573

Q28263849-1343317C-555B-4CC1-BAFB-A8A9E588C5D1

Q28263849-21922DAD-3CD2-4A2E-B63D-4D9F78395BA8

Q28263849-32335D39-335F-447D-869A-B2DBF438377C

Q28263849-3257DF10-B57E-4350-820F-A52DC3285795

Q28263849-33E89AD4-2CD4-4662-85AE-1270ACB294EE

P304

Q28263849-ED2338EF-D26A-495A-ABC1-85D6DC3CF3C6

P31

Q28263849-BC1305A6-6851-43AD-9F7A-9E0194DE9497

P356

Q28263849-F1020B44-9E6A-47DF-AE96-C147A5FFABE0

P407

Q28263849-0C99089F-ABEA-44BA-A323-16D7BFBE77BB

P433

Q28263849-FD6C72CD-DCB3-49CF-B45D-AD1334E44700

P478

Q28263849-7E7AFE96-594D-4140-BE12-3C4AF8244CFF

P50

Q28263849-3B973FBE-1C7A-464C-9114-9356EDB21562

Q28263849-61A1A677-387B-431A-A4CA-D0A7B0595030

Q28263849-7B3452AD-BB70-4807-9A3C-747E64D2C8B0

Q28263849-E5C7602F-7E13-4D39-A56A-7A9B80CD8EA2

P577

Q28263849-35B7B30B-FA74-4A88-98FD-67E03EC70428

P698

Q28263849-812737E6-8600-4330-A26C-A0F1B571789B

P921

Q28263849-B7D3385D-93EE-4E55-B3C8-CCC786610DFF

P356

P1433

Journal of Biological Chemistry

P1476

C-type lectins L-SIGN and DC-S ...... s C virus pseudotype particles

@en

P2093

Fernando Arenzana-Seisdedos

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Virelizier

http://www.w3.org/2001/XMLSchema#string

Ralf Altmeyer

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

P304

32035-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M402296200

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P50

François-Loïc Cosset

Pierre-Yves Lozach

P577

2004-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15166245

http://www.w3.org/2001/XMLSchema#string

P921

transmission of virus